Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy

• Status: Completed
• Trial end date: 2008-09-01

Summary

The purpose of this study is to evaluate the effect of topical cyclosporine ophthalmic solution 0.05% (Restasis, Allergan) on the signs and symptoms of dry eye in patients undergoing LASIK or photorefractive keratectomy (PRK).

• Phase: Phase 4

Details

• Lead Sponsor: Innovative Medical
• Treatments: Cyclosporine; Cyclosporins